PUBERTAL MATURATION OF THE LH STIMULATORY RESPONSE TO CLOMIPHENE CITRATE IN CONGENITAL VIRILIZING ADRENAL HYPERPLASIA-Reference-Cited by-同舟云学术

PUBERTAL MATURATION OF THE LH STIMULATORY RESPONSE TO CLOMIPHENE CITRATE IN CONGENITAL VIRILIZING ADRENAL HYPERPLASIA

Published:1982-11 Issue:5 Volume:17 Page:441-447
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

MOREIRA AYRTON CUSTÓDIO,VERÍSSIMO JOSÉ MOACIR TABOSA,FOSS MILTON CESAR,IAZIGI NASSIM,MACIEL LEA MARIA ZANINI,PIMENTA WALKYRIA DE PAULA,RODRIGUES JOSÉ ANTUNES,SANTORO JOSÉ ROMANO

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.1982.tb01611.x/fullpdf

Reference25 articles.

1. Growth in Congenital Adrenal Hyperplasia

2. Twenty-Four Hour Patterns of Plasma Luteinizing Hormone and Follicle-Stimulating Hormone in Sexual Precocity

3. Experience with long-term therapy in congenital adrenal hyperplasia

4. Hormonal Changes in Puberty I. Correlation of Serum Luteinizing Hormone and Follicle Stimulating Hormone with Stages of Puberty, Testicular Size, and Bone Age in Normal Boys

5. THE DETERMINATION OF URINARY STEROIDS. I. THE PREPARATION OF PIGMENT-FREE EXTRACTS AND A SIMPLIFIED PROCEDURE FOR THE ESTIMATION OF TOTAL 17-KETOSTEROIDS

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gonadotropin-dependent pubertal disorders are common in patients with virilizing adrenocortical tumors in childhood;Endocrine Connections;2019-05

2. The pharmacotherapy of male hypogonadism besides androgens;Expert Opinion on Pharmacotherapy;2014-12-19

3. Emerging medication for the treatment of male hypogonadism;Expert Opinion on Emerging Drugs;2012-05-21

4. Clomiphene fails to revert hypogonadism in most male patients with conventionally treated nonfunctioning pituitary adenomas;Arquivos Brasileiros de Endocrinologia & Metabologia;2011-06

5. Recovery of persistent hypogonadism by clomiphene in males with prolactinomas under dopamine agonist treatment;European Journal of Endocrinology;2009-07